# Craniofacial Ossifying Fibromas in Children: Clinical Variability and Surgical Outcomes in a Case Series

**Authors:** Jocelyne García-Vela, Hiram H Plata-Huerta, Josefina Alejandra Morales Del Angel, Dariana Rodriguez

PMC · DOI: 10.7759/cureus.102062 · 2026-01-22

## TL;DR

This paper presents three cases of rare craniofacial tumors in children, showing how surgical techniques can effectively manage these tumors with minimal complications.

## Contribution

The study provides new clinical insights and surgical outcomes for managing juvenile ossifying fibroma in pediatric patients.

## Key findings

- Endoscopic tumor resection with combined approaches achieved complete access and no permanent deficits in three pediatric cases.
- No radiologic recurrence was observed at six-month follow-up, highlighting the effectiveness of complete excision.
- Early diagnosis and multidisciplinary management are crucial for optimizing outcomes in these rare tumors.

## Abstract

Juvenile ossifying fibroma (JOF) is a rare benign fibro-osseous tumor affecting the craniofacial skeleton in children and adolescents. Although nonmalignant, it may behave aggressively and extend into adjacent structures such as the orbit or anterior skull base. Early symptoms are often subtle, delaying diagnosis. Two histologic variants exist - trabecular and psammomatoid - each with distinct clinical behavior and recurrence potential. We describe a case series of three pediatric patients (an 8-year-old male, a 13-year-old female, and a 16-year-old male) diagnosed with craniofacial JOF between March 2022 and January 2025. Presenting symptoms included progressive facial deformity, nasal obstruction, and proptosis. Imaging demonstrated expansile, well-defined lesions involving the ethmoid, maxillary, frontal, and sphenoid sinuses, with orbital displacement in all cases and anterior cranial fossa extension in one. All patients underwent endoscopic tumor resection; two required combined external approaches (Caldwell-Luc and Lynch incision) to achieve complete access. Significant intraoperative bleeding occurred in two cases but was successfully controlled. No permanent visual or neurological deficits were observed. At the six-month follow-up, none showed radiologic recurrence. JOF in pediatric patients is rare and may exhibit locally aggressive behavior, posing diagnostic and surgical challenges. Radiologic and histopathologic evaluation are essential for accurate differentiation from other fibro-osseous lesions. Complete excision via endoscopic or combined approaches provides excellent visualization and low morbidity while preserving function. Early recognition and multidisciplinary management optimize outcomes. Long-term imaging surveillance remains crucial due to the risk of late recurrence.

## Linked entities

- **Diseases:** juvenile ossifying fibroma (MONDO:0002119)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** inflammatory or vascular lesions (MESH:D014652), benign neoplasm (MESH:D009369), Fibro-osseous lesions (MESH:D000070896), edema (MESH:D004487), blood loss (MESH:D016063), deviation (MESH:D010262), headaches (MESH:D006261), inflammation (MESH:D007249), dehiscence (MESH:D013529), fibrous dysplasia (MESH:D005357), pain (MESH:D010146), visual impairment (MESH:D014786), bronchospasm (MESH:D001986), respiratory distress (MESH:D012128), fever (MESH:D005334), facial pain (MESH:D005157), hypotension (MESH:D007022), neurological deficits (MESH:D009461), proptosis (MESH:D005094), mucocele (MESH:D009078), fibro-osseous or neoplastic entities (MESH:D009810), nasal polyps (MESH:D009298), benign maxillary tumors (MESH:D008441), osteoma (MESH:D010016), bleeding (MESH:D006470), febrile (MESH:D000071072), epistaxis (MESH:D004844), nasal congestion (MESH:D009668), hard palate (MESH:D018804), infection (MESH:D007239), Bone erosion of (MESH:D014077), bone deformity (MESH:D001847), pyogenic granuloma (MESH:D017789), blood (MESH:D006402), diplopia (MESH:D004172), erythema (MESH:D004890), nasal obstruction (MESH:D015508), JNA (MESH:D018322), infectious disease (MESH:D003141), monostotic fibrous dysplasia (MESH:D005358), epiphora (MESH:D007766), facial deformity (MESH:D005153), sinonasal tumors (MESH:C537344), juvenile ossifying fibroma (MESH:D018214)
- **Chemicals:** metronidazole (MESH:D008795), oxygen (MESH:D010100), norepinephrine (MESH:D009638), vancomycin (MESH:D014640), ceftriaxone (MESH:D002443), trimethoprim-sulfamethoxazole (MESH:D015662)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12924643/full.md

---
Source: https://tomesphere.com/paper/PMC12924643